Cargando…
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Pancreatic adenocarcinoma is a lethal cancer with poor response to chemotherapy and immune checkpoint inhibitors. Recent studies suggest that epigenetic alterations contribute to its aggressive biology and the tumor microenvironment which render it unresponsive to immune checkpoint blockade. Here, w...
Autores principales: | Kawakubo, Kazumichi, Castillo, Carlos Fernandez-del, Liss, Andrew Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596544/ https://www.ncbi.nlm.nih.gov/pubmed/36048239 http://dx.doi.org/10.1007/s00535-022-01915-2 |
Ejemplares similares
-
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
por: Kawakubo, Kazumichi, et al.
Publicado: (2022) -
Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022) -
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
por: Thompson, Joyce K., et al.
Publicado: (2021) -
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
por: Daniel, S. K., et al.
Publicado: (2019) -
Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
por: Hester, Robert, et al.
Publicado: (2021)